Vimarsana.com

Latest Breaking News On - Metastatic crc - Page 1 : vimarsana.com

Evaluating 3L Treatment Landscape Evolution

Dr Parikh drives a conversation surrounding 3L treatment for patients diagnosed with metastatic colorectal cancer.

Expert-perspectives
Evolving-treatment
Refractory-metastatic-colorectal-cancer
Treatment-landscape
Colorectal-cancer
Crc
Colorectal-cancer-treatment
Crc-treatment
Third-line-therapy
Third-line-treatment
Metastatic-colorectal-cancer

Audience Q&A: Best Practices in Managing HER2-Amplified CRC

Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.

Positive-colorectal-cancer
Novel-approaches
Best-practices
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Trastuzumab-deruxtecan
Tdxd

Real-World Use of HER2-Directed Therapies in Colorectal Cancers

Expert perspectives on the real-world use of HER2-directed therapies in patients with HER2-amplified colorectal cancer.

Positive-colorectal-cancer
Novel-approaches
World-use
Directed-therapies
Colorectal-cancers
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive

Evolutions in the HER2-Amplified CRC Treatment Landscape

Looking toward the future management of HER2-amplified colorectal cancer, panelists reflect on ongoing clinical trials and evolving treatment strategies.

Positive-colorectal-cancer
Novel-approaches
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Trastuzumab-deruxtecan
Tdxd
T-dxd

Treatment Algorithm for Metastatic Colorectal Cancer

Broadening their conversation, expert oncologists define the treatment algorithm for patients diagnosed with colorectal cancer.

Positive-colorectal-cancer
Novel-approaches
Metastatic-colorectal
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Vegf
Egfr

HER2-Amplified Colorectal Cancer: Clinical Trial Data

A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.

Positive-colorectal-cancer
Novel-approaches
Amplified-colorectal-cancer
Clinical-trial-data
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Tucatinib

Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes

Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.

Positive-colorectal-cancer
Novel-approaches
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Biomarker-testing
Molecular-testing
Molecular-lab-test

Colorectal Cancer: An Overview on Molecular Profiling

Shared insight on appropriate molecular lab testing options that should be explored following a diagnosis of colorectal cancer.

Positive-colorectal-cancer
Novel-approaches
Molecular-profiling
Colorectal-cancer
Metastatic-crc
Colon-cancer
Rectal-cancer
Her2
Her2-positive
Biomarker-testing
Molecular-testing

Metastatic Colorectal Cancer: Future Directions in Care

Expert panelists identify key takeaways and share their excitement for future directions in the management of metastatic colorectal cancer.

Metastatic-colorectal-cancer-with
Positive-disease
Colorectal-cancer
Future-directions
Crc
Metastatic-crc
Mcrc
Ngs
Next-generation-sequencing
Molecular-testing
Biomarker-testing

Novel Combination Strategies in mCRC: The STELLAR-303 and SUNLIGHT Trials

Before closing out their review of combination therapy in metastatic colorectal cancer, panelists discuss the STELLAR-303 and SUNLIGHT clinical trials.

Metastatic-colorectal-cancer-with
Positive-disease
Combination-strategies
Colorectal-cancer
Crc
Metastatic-crc
Mcrc
Immunotherapy
Immune-checkpoint-inhibitors
Tki-therapy
Tyrosine-kinase-inhibitors

vimarsana © 2020. All Rights Reserved.